Rationale for the use of L-dopa in the torsion dystonias.
D000818:Animals; D001479:Basal Ganglia / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects; D004298:Dopamine / Q000378:metabolism; D004422:Dystonia Musculorum Deformans / Q000188:drug therapy*; D000882:Haplorhini; D006801:Humans; D006948:Hyperkinesis / Q000139:chemically induced; D020149:Manganese Poisoning; D009069:Movement Disorders / Q000139:chemically induced; D010300:Parkinson Disease / Q000378:metabolism; D010640:Phenothiazines / Q000009:adverse effects
D010640:Phenothiazines; D004295:Dihydroxyphenylalanine; D004298:Dopamine